-
Something wrong with this record ?
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative
S. Ozen, SD. Marks, P. Brogan, N. Groot, N. de Graeff, T. Avcin, B. Bader-Meunier, P. Dolezalova, BM. Feldman, I. Kone-Paut, P. Lahdenne, L. McCann, C. Pilkington, A. Ravelli, A. van Royen, Y. Uziel, B. Vastert, N. Wulffraat, S. Kamphuis, MW. Beresford,
Language English Country Great Britain
Document type Consensus Development Conference, Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
Medline Complete (EBSCOhost)
from 1999-01-01 to 1 year ago
- MeSH
- Analgesia methods MeSH
- Biopsy MeSH
- Child MeSH
- Gastrointestinal Diseases diagnosis etiology MeSH
- Glucocorticoids therapeutic use MeSH
- Glomerulonephritis, IGA diagnosis drug therapy etiology pathology MeSH
- IgA Vasculitis complications diagnosis drug therapy pathology MeSH
- Immunoglobulin A analysis MeSH
- Angiotensin-Converting Enzyme Inhibitors therapeutic use MeSH
- Skin pathology MeSH
- Kidney pathology MeSH
- Humans MeSH
- Evidence-Based Medicine methods MeSH
- Severity of Illness Index MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Consensus Development Conference MeSH
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatment of IgAV in children. Accordingly, treatment regimens differ widely. The European initiative SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) aims to optimize care for children with rheumatic diseases. The aim therefore was to provide internationally agreed consensus recommendations for diagnosis and treatment for children with IgAV. METHODS: Recommendations were developed by a consensus process in accordance with the EULAR standard operating procedures. An extensive systematic literature review was performed, and evidence-based recommendations were extrapolated from the included papers. These were evaluated by a panel of 16 international experts via online surveys and subsequent consensus meeting, using nominal group technique. Recommendations were accepted when ⩾80% of experts agreed. RESULTS: In total, 7 recommendations for diagnosis and 19 for treatment of paediatric IgAV were accepted. Diagnostic recommendations included: appropriate use of skin and renal biopsy, renal work-up and imaging. Treatment recommendations included: the importance of appropriate analgesia and angiotensin-converting enzyme inhibitor use and non-renal indications for CS use, as well as a structured approach to treating IgAV nephritis, including appropriate use of CS and second-line agents in mild, moderate and severe disease along with use of angiotensin-converting enzyme inhibitors and maintenance therapy. CONCLUSION: The SHARE initiative provides international, evidence-based recommendations for the diagnosis and treatment of IgAV that will facilitate improvement and uniformity of care.
Department of Paediatric Rheumatology Alder Hey Children's NHS Foundation Trust Liverpool UK
Department of Paediatric Rheumatology Bicêtre University Hospital Paris France
Department of Paediatric Rheumatology University Children's Hospital Ljubljana Ljubljana Slovenia
Department of Paediatrics Hacettepe University Ankara Turkey
Gaslini Children's Hospital Genoa Italy
General University Hospital and 1 Faculty of Medicine Charles University Prague Czech Republic
Hospital for Children and Adolescents University of Helsinki Helsinki Finland
Meir Medical Centre Tel Aviv University Tel Aviv Israel
Necker Hospital Assistance Publique Hôpitaux de Paris Paris France
Sophia Children's Hospital Erasmus University Medical Centre Rotterdam The Netherlands
The Hospital for Sick Children University of Toronto Toronto Canada
Wilhelmina Children's Hospital University Medical Center Utrecht
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006527
- 003
- CZ-PrNML
- 005
- 20200518132733.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/rheumatology/kez041 $2 doi
- 035 __
- $a (PubMed)30879080
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Ozen, Seza $u Department of Paediatrics, Hacettepe University, Ankara, Turkey.
- 245 10
- $a European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative / $c S. Ozen, SD. Marks, P. Brogan, N. Groot, N. de Graeff, T. Avcin, B. Bader-Meunier, P. Dolezalova, BM. Feldman, I. Kone-Paut, P. Lahdenne, L. McCann, C. Pilkington, A. Ravelli, A. van Royen, Y. Uziel, B. Vastert, N. Wulffraat, S. Kamphuis, MW. Beresford,
- 520 9_
- $a OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatment of IgAV in children. Accordingly, treatment regimens differ widely. The European initiative SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) aims to optimize care for children with rheumatic diseases. The aim therefore was to provide internationally agreed consensus recommendations for diagnosis and treatment for children with IgAV. METHODS: Recommendations were developed by a consensus process in accordance with the EULAR standard operating procedures. An extensive systematic literature review was performed, and evidence-based recommendations were extrapolated from the included papers. These were evaluated by a panel of 16 international experts via online surveys and subsequent consensus meeting, using nominal group technique. Recommendations were accepted when ⩾80% of experts agreed. RESULTS: In total, 7 recommendations for diagnosis and 19 for treatment of paediatric IgAV were accepted. Diagnostic recommendations included: appropriate use of skin and renal biopsy, renal work-up and imaging. Treatment recommendations included: the importance of appropriate analgesia and angiotensin-converting enzyme inhibitor use and non-renal indications for CS use, as well as a structured approach to treating IgAV nephritis, including appropriate use of CS and second-line agents in mild, moderate and severe disease along with use of angiotensin-converting enzyme inhibitors and maintenance therapy. CONCLUSION: The SHARE initiative provides international, evidence-based recommendations for the diagnosis and treatment of IgAV that will facilitate improvement and uniformity of care.
- 650 _2
- $a analgezie $x metody $7 D000698
- 650 _2
- $a inhibitory ACE $x terapeutické užití $7 D000806
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a medicína založená na důkazech $x metody $7 D019317
- 650 _2
- $a gastrointestinální nemoci $x diagnóza $x etiologie $7 D005767
- 650 _2
- $a IgA nefropatie $x diagnóza $x farmakoterapie $x etiologie $x patologie $7 D005922
- 650 _2
- $a glukokortikoidy $x terapeutické užití $7 D005938
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobulin A $x analýza $7 D007070
- 650 _2
- $a ledviny $x patologie $7 D007668
- 650 _2
- $a IgA vaskulitida $x komplikace $x diagnóza $x farmakoterapie $x patologie $7 D011695
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a kůže $x patologie $7 D012867
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Marks, Stephen D $u Great Ormond Street Hospital for Children NHS Foundation Trust, University College London Great Ormond Street Institute of Child Health, London, UK.
- 700 1_
- $a Brogan, Paul $u Great Ormond Street Hospital for Children NHS Foundation Trust, University College London Great Ormond Street Institute of Child Health, London, UK.
- 700 1_
- $a Groot, Noortje $u Wilhelmina Children's Hospital, University Medical Center, Utrecht. Sophia Children's Hospital, Erasmus University Medical Centre, Rotterdam, The Netherlands. Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
- 700 1_
- $a de Graeff, Nienke $u Wilhelmina Children's Hospital, University Medical Center, Utrecht.
- 700 1_
- $a Avcin, Tadej $u Department of Paediatric Rheumatology, University Children's Hospital Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Bader-Meunier, Brigitte $u Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- 700 1_
- $a Dolezalova, Pavla $u General University Hospital and 1 Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Feldman, Brian M $u The Hospital for Sick Children, University of Toronto, Toronto, Canada.
- 700 1_
- $a Kone-Paut, Isabelle $u Department of Paediatric Rheumatology, Bicêtre University Hospital, Paris, France.
- 700 1_
- $a Lahdenne, Pekka $u Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a McCann, Liza $u Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
- 700 1_
- $a Pilkington, Clarissa $u Great Ormond Street Hospital for Children NHS Foundation Trust, University College London Great Ormond Street Institute of Child Health, London, UK.
- 700 1_
- $a Ravelli, Angelo $u Gaslini Children's Hospital, Genoa, Italy.
- 700 1_
- $a van Royen, Annet $u Wilhelmina Children's Hospital, University Medical Center, Utrecht.
- 700 1_
- $a Uziel, Yosef $u Meir Medical Centre, Tel Aviv University, Tel Aviv, Israel.
- 700 1_
- $a Vastert, Bas $u Wilhelmina Children's Hospital, University Medical Center, Utrecht.
- 700 1_
- $a Wulffraat, Nico $u Wilhelmina Children's Hospital, University Medical Center, Utrecht.
- 700 1_
- $a Kamphuis, Sylvia $u Sophia Children's Hospital, Erasmus University Medical Centre, Rotterdam, The Netherlands.
- 700 1_
- $a Beresford, Michael W $u Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Institute of Translational Medicine, University of Liverpool and Alder Hey children's NHS Foundation Trust, Members of Liverpool Health Partners, Liverpool, UK.
- 773 0_
- $w MED00011379 $t Rheumatology (Oxford, England) $x 1462-0332 $g Roč. 58, č. 9 (2019), s. 1607-1616
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30879080 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132732 $b ABA008
- 999 __
- $a ok $b bmc $g 1525385 $s 1096583
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 58 $c 9 $d 1607-1616 $e 20190901 $i 1462-0332 $m Rheumatology $n Rheumatology (Oxford) $x MED00011379
- LZP __
- $a Pubmed-20200511
